StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$941.25−6.27 (-0.66%)

Close on Nov 18, 2026Market cap –P/E 48.1Yield –

argenx shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 66M, up 1.3% from the year before. Over ten years it grew 15.4% a year on average. The highest annual figure on record is 66M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202566M+1.3%
FY2024Dec 31, 202465M+14.0%
FY2023Dec 31, 202357M+5.1%
FY2022Dec 31, 202254M+6.5%
FY2021Dec 31, 202151M+12.5%
FY2020Dec 31, 202045M+17.6%
FY2019Dec 31, 201939M+15.6%
FY2018Dec 31, 201833M+35.8%
FY2017Dec 31, 201725M+30.8%
FY2016Dec 31, 201619M+19.6%
FY2015Dec 31, 201516M–

More argenx figures

See a number that looks wrong?